Table 3 Distribution of treatment lines over the study years, mRCC patients, Estonia 2004–2012
From: Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
2004–2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2004–2012 | |
|---|---|---|---|---|---|---|---|
Treatment lines | |||||||
First line | 154 (100) | 26 (100) | 50 (100) | 47 (100) | 58 (100) | 62 (100) | 397 (100) |
Second line | 6 (4) | 16 (62) | 21 (42) | 24 (51) | 24 (41) | 19 (31) | 110 (28) |
Third line | 0 (0) | 5 (19) | 8 (16) | 15 (32) | 18 (31) | 11 (18) | 57 (14) |
Fourth line | 0 (0) | 0 (0) | 2 (4) | 2 (4) | 3 (5) | 3 (5) | 10 (3) |